Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00053246.xml
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2022; 05(04): 135-137
DOI: 10.1055/s-0043-1761205
DOI: 10.1055/s-0043-1761205
Viewpoint
Guidelines on the Management of Type 2 Diabetes
Financial Support and Sponsorship Nil.
Authors Contribution
This viewpoint was written by Miles Fisher who approved the final version for publication.
Compliance with Ethical Principles
Ethical approval is not required.
Publication History
Article published online:
16 March 2023
© 2023. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Alawadi F, Abusnana S, Afandi B. et al. Emirates Diabetes Society Consensus Guidelines for the management of type 2 diabetes – 2020. Dubai Diabetes Endocrinol J 2020; 26: 1-20
- 2 Cosentino F, Grant PJ, Aboyans V. et al; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41 (02) 255-323
- 3 American Diabetes Association Standards of medical care in diabetes - 2020. Pharmacological approaches to glycemic treatment. Diabetes Care 2020; 43:S98–S110.
- 4 SIGN 50: a guideline developer's handbook. Accessed January 6, 2023 at: https://www.sign.ac.uk/what-we-do/methodology/sign-50-a-guideline-developers-handbook/
- 5 Fisher M, Drummond R. Guidelines on antidiabetic drugs. In: Fisher M. McKay GA, Llano A, eds. Diabetes Drug Notes. Hoboken, NJ: Wiley Blackwell; 2022: 294-321
- 6 IDF Clinical practice recommendations for managing type 2 diabetes in primary care. International Diabetes federation – 2017. Accessed January 6, 2023 at: https://www.idf.org/e-library/guidelines/128-idf-clinical-practice-recommendations-for-managing-type-2-diabetes-in-primary-care.html
- 7 European Society of Cardiology Guidelines publications schedule. Accessed January 6, 2023 at: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/ESC-Guidelines-Publication-Schedule
- 8 NICE. Type 2 diabetes in adults: management. NICE Guideline [NG28]. Published: 02 Dec 2015. Accessed January 6, 2023 at: https://www.nice.org.uk/guidance/ng28
- 9 NICE. Type 2 diabetes in adults: management (medicines update). Accessed January 6, 2023 at: https://www.nice.org.uk/guidance/indevelopment/gid-ng10336
- 10 American Diabetes Association Standards of medical care in diabetes - 2023. Pharmacological approaches to glycemic treatment. Diabetes Care 2023; 46: S140-S157
- 11 Davies MJ, D'Alessio DA, Fradkin J. et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2018; 61 (12) 2461-2498
- 12 Buse JB, Wexler DJ, Tsapas A. et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2020; 63 (02) 221-228
- 13 Davies MJ, Aroda VR, Collins BS. et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2022; 65 (12) 1925-1966
- 14 IDF-DAR practical guidelines 2021. Diabetes and Ramadan. Practical guidelines 2021. Accessed January 6, 2023 at: https://www.idf.org/e-library/guidelines/165-idf-dar-practical-guidelines-2021.html